Ticker
ATAICompany Name
ATAI LIFE SCIENCES NVSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -115.37M | -4996.41% | $ 2.31M |
3/31/2025 | $ -144.77M | -7770.75% | $ 1.86M |
12/31/2024 | $ -145.61M | -47276.62% | $ 308K |
9/30/2024 | $ -124.54M | -37625.68% | $ 331K |
6/30/2024 | $ -53.76M | -14221.16% | $ 378K |
3/31/2024 | $ -29.43M | -10624.91% | $ 277K |
12/31/2023 | $ -35.85M | -11417.2% | $ 314K |
9/30/2023 | $ -58.12M | -17400.3% | $ 334K |
6/30/2023 | $ -137.07M | -50581.18% | $ 271K |
3/31/2023 | $ -141.5M | -52603.35% | $ 269K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / Revenues
(=) EBITDA %
EBITDA % for ATAI LIFE SCIENCES NV is calculated as follows: EBITDA [ $ -169.51M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ]
Minimum
Dec 31, 2022
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.29K |
---|---|
min | -74.98% |
max | 97.73% |
average | 16.16% |
median | 14.74% |
std | 26.84% |